$622 Million is the total value of SECTOR GAMMA AS's 34 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 21.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $61,301,000 | -5.4% | 1,351,722 | -0.5% | 9.85% | -5.2% |
| ABT | Sell | ABBOTT LABS | $57,799,000 | -5.3% | 687,260 | -10.0% | 9.29% | -5.1% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $47,636,000 | +11.3% | 1,108,336 | -0.6% | 7.66% | +11.6% |
| BAX | Buy | BAXTER INTL INC | $37,863,000 | +3.9% | 462,305 | +3.1% | 6.09% | +4.1% |
| GILD | Sell | GILEAD SCIENCES INC | $30,068,000 | -20.1% | 445,056 | -23.1% | 4.83% | -19.9% |
| NUVA | Sell | NUVASIVE INC | $29,232,000 | -4.4% | 499,354 | -7.3% | 4.70% | -4.2% |
| PKI | Sell | PERKINELMER INC | $28,921,000 | -12.5% | 300,198 | -12.5% | 4.65% | -12.3% |
| BIIB | Sell | BIOGEN INC | $26,925,000 | -24.2% | 115,126 | -23.4% | 4.33% | -24.0% |
| INCY | Buy | INCYTE CORP | $26,668,000 | +18.7% | 313,893 | +20.1% | 4.29% | +19.0% |
| BIO | Sell | BIO RAD LABS INCcl a | $26,578,000 | -0.5% | 85,026 | -2.7% | 4.27% | -0.3% |
| A | Buy | AGILENT TECHNOLOGIES INC | $21,584,000 | -4.2% | 289,065 | +3.1% | 3.47% | -4.0% |
| ANTM | Buy | ANTHEM INC | $20,632,000 | +84.3% | 73,107 | +87.4% | 3.32% | +84.6% |
| REGN | New | REGENERON PHARMACEUTICALS | $18,040,000 | – | 57,635 | +100.0% | 2.90% | – |
| HUM | New | HUMANA INC | $17,749,000 | – | 66,900 | +100.0% | 2.85% | – |
| QGEN | Buy | QIAGEN NV | $17,173,000 | +6.3% | 423,501 | +6.7% | 2.76% | +6.6% |
| TAK | Buy | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $14,094,000 | +6.9% | 796,299 | +23.0% | 2.26% | +7.1% |
| PRGO | Sell | PERRIGO CO PLC | $13,231,000 | -10.8% | 277,844 | -9.8% | 2.13% | -10.6% |
| BRKR | New | BRUKER CORP | $11,139,000 | – | 223,004 | +100.0% | 1.79% | – |
| PDCO | Buy | PATTERSON COMPANIES INC | $10,746,000 | +9.2% | 469,255 | +4.2% | 1.73% | +9.4% |
| PTCT | Buy | PTC THERAPEUTICS INC | $10,327,000 | +40.9% | 229,498 | +17.8% | 1.66% | +41.2% |
| MYL | Sell | MYLAN N V | $9,607,000 | -57.1% | 504,592 | -36.2% | 1.54% | -57.0% |
| CVS | Sell | CVS HEALTH CORP | $9,576,000 | -40.6% | 175,743 | -41.2% | 1.54% | -40.4% |
| CAH | Buy | CARDINAL HEALTH INC | $9,293,000 | +18.7% | 197,299 | +21.3% | 1.49% | +18.9% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $8,452,000 | -55.4% | 131,514 | -43.7% | 1.36% | -55.3% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $8,442,000 | +0.3% | 64,742 | +2.9% | 1.36% | +0.5% |
| THC | Buy | TENET HEALTHCARE CORP | $6,790,000 | +7.7% | 328,662 | +50.3% | 1.09% | +7.9% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $6,415,000 | -31.9% | 431,425 | +13.6% | 1.03% | -31.8% |
| ELAN | Sell | ELANCO ANIMAL HEALTH INC | $6,254,000 | -10.9% | 185,042 | -15.5% | 1.00% | -10.7% |
| MCK | Sell | MCKESSON CORP | $5,937,000 | +2.5% | 44,175 | -10.8% | 0.95% | +2.7% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $5,532,000 | -37.4% | 203,925 | -19.9% | 0.89% | -37.2% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $5,217,000 | – | 71,900 | +100.0% | 0.84% | – |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $5,133,000 | +33.4% | 102,913 | +80.4% | 0.82% | +33.7% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $5,058,000 | +10.6% | 79,653 | +20.8% | 0.81% | +10.9% |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $2,711,000 | +19.0% | 251,698 | +5.4% | 0.44% | +19.5% |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -376,502 | -100.0% | -0.34% | – |
| RDY | Exit | DR REDDYS LABS LTDadr | $0 | – | -88,076 | -100.0% | -0.57% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -119,352 | -100.0% | -1.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-07-31
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.